Cancer Genetics (United States)
In research, Cancer Genetics (United States) stands highest in Life Sciences (#1,994 of 7,800 worldwide), Biochemistry, Genetics and Molecular Biology (#1,458 of 3,579 worldwide) and Molecular Biology (#1,037 of 2,175 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Genetics and Oncology — Cancer Research is 16.9× its share of world research.
- World rank, 2022–2025
- #4,982 of 28,054 · #1,924 all time
- Rank in United States
- #689 of 4,192
- Research works
- 2.8k ▼ 10% vs 2013–17
- Citations
- 231k 83.7 per fractional work
- Top-10% rate
- 24.7% record average 16.5%
- Open access
- 55% world 28%
What is Cancer Genetics (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,994 of 7,800 | 26.3% | 140 | #694 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,458 of 3,579 | 27.2% | 116 | #574 | |
| Molecular BiologySubfield | #1,037 of 2,175 | 31.5% | 61 | #330 | |
| MedicineField | #5,026 of 10,443 | 22.5% | 118 | #1249 | |
| Health SciencesDomain | #6,499 of 11,982 | 22.6% | 123 | #1621 |
Each strip is that field’s whole ranked pool, with the notch where Cancer Genetics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#694 #1,994
- Biochemistry, Genetics and Molecular Biology#574 #1,458
- Molecular Biology#330 #1,037
- Medicine#1,249 #5,026
- Health Sciences#1,621 #6,499
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Cancer Genetics (United States) specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 16.9× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 20.4 works17×
- GeneticsSubfield · 28.1 works12×
- OncologySubfield · 34.3 works11×
- Biochemistry, Genetics and Molecular BiologyField · 116.4 works7.8×
- Molecular BiologySubfield · 61.0 works7.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.8×
- Immunology and Microbiology 5.1×
- Veterinary 4.7×
- Medicine 2.2×
- Neuroscience 0.9×
- Nursing 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Agricultural and Biological Sciences 0.3×
- Economics, Econometrics and Finance 0.2×
- Chemistry 0.2×
- Health Professions 0.2×
- Dentistry 0.2×
- Psychology 0.2×
- Mathematics 0.2×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Materials Science 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.1×
- Earth and Planetary Sciences 0.0×
- Engineering 0.0×
- Chemical Engineering 0.0×
- Energy 0.0×
Who are the top researchers at Cancer Genetics (United States)?
Ranked on the composite score, Antonio Iavarone, Richard Baer and Shyam K. Sharan lead among researchers whose main affiliation is Cancer Genetics (United States).
- 1 Antonio Iavarone United States · #124,452 worldwide 299 citations · 45 works
- 2 Richard Baer United States · #141,440 worldwide 281 citations · 21 works
- 3 Shyam K. Sharan United States · #588,599 worldwide 60 citations · 17 works
Which keywords describe research at Cancer Genetics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Cancer Risk, Genetic Testing, Breast Cancer, Precision Medicine, Genomic Instability, Gene Expression and Ovarian Cancer.
- Neoadjuvant Therapy
- Cancer Incidence
- Histone Modification
- Epigenetic Reprogramming
- Epigenetic Regulation
- Metastasis
- Genetic Mutations
- Hereditary Syndromes
- Regulation
- Cancer Genomics
- Homologous Recombination
- Chromatin
- Targeted Therapy
- Chemotherapy
- BRCA1
- Immunotherapy
- Ovarian Cancer
- Genomic Instability
- Breast Cancer
- Cancer Risk
- Cancer
- Genetic Testing
- Precision Medicine
- Gene Expression
- Cancer Therapy
- Inflammation
- BRCA2
- Tumor Microenvironment
- Molecular Characterization
- Cell-Free DNA
- Prognostic Factors
- Mutational Signatures
- Adjuvant Chemotherapy
- Microsatellite Instability
- DNA Damage
- DNA Methylation
- Cell Death
- Cancer Epigenetics
- ATM and ATR Kinases
- Repair
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer33▲ 8.8×40 topics
- Cancer Risk22▲ 36×7 topics
- Genetic Testing21▲ 68×3 topics
- Breast Cancer19▲ 29×11 topics
- Precision Medicine17▲ 13×7 topics
- Genomic Instability16▲ 52×3 topics
- Gene Expression15▲ 8.9×14 topics
- Ovarian Cancer14▲ 59×3 topics
- Cancer Therapy14▲ 8.6×15 topics
- Immunotherapy14▲ 6.8×19 topics
- Inflammation13▲ 2.3×49 topics
- BRCA113▲ 181×1 topic
- BRCA213▲ 181×1 topic
- Chemotherapy13▲ 6.8×21 topics
- Tumor Microenvironment12▲ 9.6×8 topics
- Targeted Therapy11▲ 18×5 topics
- Molecular Characterization10▲ 21×6 topics
- Chromatin10▲ 77×2 topics
- Cell-Free DNA10▲ 35×2 topics
- Homologous Recombination10▲ 77×2 topics
- Prognostic Factors10▲ 7.9×12 topics
- Cancer Genomics9▲ 45×1 topic
- Mutational Signatures9▲ 45×1 topic
- Regulation9▲ 6.0×8 topics
- Adjuvant Chemotherapy8▲ 42×2 topics
- Hereditary Syndromes8▲ 94×1 topic
- Microsatellite Instability8▲ 94×1 topic
- Genetic Mutations8▲ 6.5×17 topics
- DNA Damage8▲ 35×3 topics
- Metastasis7▲ 7.8×10 topics
- DNA Methylation7▲ 23×3 topics
- Epigenetic Regulation7▲ 12×6 topics
- Cell Death7▲ 11×6 topics
- Epigenetic Reprogramming7▲ 28×2 topics
- Cancer Epigenetics7▲ 35×1 topic
- Histone Modification7▲ 35×1 topic
- ATM and ATR Kinases7▲ 105×1 topic
- Cancer Incidence7▲ 18×4 topics
- Repair7▲ 105×1 topic
- Neoadjuvant Therapy6▲ 10.0×5 topics
Which research topics does Cancer Genetics (United States) publish most on?
By volume in 2022–2025: BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer and Epigenetics and DNA Methylation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 BRCA gene mutations in cancer Genetics 13 works
- 2 Cancer Genomics and Diagnostics Cancer Research 9 works
- 3 Genetic factors in colorectal cancer Pathology and Forensic Medicine 8 works
- 4 Epigenetics and DNA Methylation Molecular Biology 7 works
- 5 DNA Repair Mechanisms Molecular Biology 7 works
- 6 RNA modifications and cancer Molecular Biology 4 works
- 7 Genomics and Rare Diseases Genetics 4 works
- 8 Genomics and Chromatin Dynamics Molecular Biology 4 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 10 CRISPR and Genetic Engineering Molecular Biology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cancer Genetics (United States)'s research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rutherford
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.